Discontinued — last reported Q1 '16

Other

Payment related to business acquisition

Over 4 years (FY 2021 to FY 2025), Payment related to business acquisition shows an upward trend with a 33.9% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ1 2016

How to read this metric

High levels of spending indicate an aggressive growth-by-acquisition strategy, which carries integration risks and potential for future value creation.

Detailed definition

The total cash outflow used to acquire other businesses or entities during the reporting period, before accounting for c...

Peer comparison

Standard for all companies; essential for assessing the intensity of inorganic growth strategies compared to peers.

Metric ID: other_payments_to_acquire_businesses_gross

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$10.89M$0.00$35.92M$0.00$6.87M$19.10M$992.13M$0.00$3.89M$104.48M$7.51M$3.08M$19.70M$855.00K$670.00K$0.00$138.58M$522.00K$0.00$24.88M
QoQ Change-100.0%-100.0%+178.1%>999%-100.0%>999%-92.8%-59.0%+539.7%-95.7%-21.6%-100.0%-99.6%-100.0%
YoY Change-36.9%>999%-43.4%+447.0%-99.2%+407.0%-99.2%-91.1%-100.0%+603.5%-38.9%-100.0%
Range$0.00$992.13M
CAGR+19.0%
Avg YoY Growth+292.6%
Median YoY Growth-41.2%

Frequently Asked Questions

What is ResMed's payment related to business acquisition?
ResMed (RMD) reported payment related to business acquisition of $24.88M in Q1 2026.
What is the long-term trend for ResMed's payment related to business acquisition?
Over 4 years (2021 to 2025), ResMed's payment related to business acquisition has grown at a 33.9% compound annual growth rate (CAGR), from $43.57M to $140.10M.
What does payment related to business acquisition mean?
The total cash spent to buy other companies.